Newsstand Menu

CSHL Stories and Media archive for Tag: Adrian Krainer

Image of faculty and staff at the CSHL waterfront

President’s essay: We are science, and science is crucial

6/2/2025

With public research funding under threat in the U.S., CSHL President Bruce Stillman outlines the stakes for people in our communities and abroad. Read the story »

2024 Double Helix Medal recipient Dr. Katalin Karikó

12/10/2024

She created the blueprint for mRNA vaccines. This year, Cold Spring Harbor Laboratory recognized her groundbreaking research and pioneering spirit. Watch the video »

Adrian Krainer wins Albany Prize for biomedical research

10/8/2024

A pioneer in the burgeoning field of RNA therapeutics, Krainer has now received America’s second-highest prize in medicine. Read the story »

RNA splicing’s spotters

6/10/2024

RNA therapeutics pioneer CSHL Professor Adrian Krainer has discovered a link between two important regulator proteins, SRSF1 and DDX23. Read the story »

image of Katalin Karikó, Bruce Stillman, and Z. Josh Huang at the 2023 CSHL Recombinant DNA meeting

President’s essay: The continuous cycle of discovery

5/30/2024

CSHL President & CEO Bruce Stillman discusses our institution’s societal impacts and global connections as forces for further scientific progress. Read the story »

Why some RNA drugs work better than others

3/6/2024

CSHL’s Justin Kinney and Spinraza inventor Adrian Krainer tested the newly approved SMA treatment, risdiplam, and another RNA therapeutic, branaplam. Read the story »

Laying the groundwork for drug discoveries

8/8/2023

A new partnership between CSHL and one of the world’s leading biotech investors could streamline this process and help change society for the better. Read the story »

Eight serving one: CSHL volleyball mid-season report

8/2/2023

CSHL’s 32nd Volleyball League season sees eight teams battling for the coveted Tiernan Cup and a year’s worth of bragging rights. Read the story »

Adrian Krainer awarded honorary IADR membership

6/21/2023

Krainer was recognized for his pioneering research on spinal muscular atrophy and RNA therapeutics. Read the story »

President’s essay: Bringing bold visions to life

5/26/2023

CSHL President & CEO Bruce Stillman sees the Laboratory as a global hub for scientific expertise and a powerful launchpad for early-career scientists. Read the story »

Image of mouse pancreas cells with SRSF1 protein

This killer protein causes pancreatic cancer

4/26/2023

CSHL researchers have found that high levels of a protein called SRSF1 can cause pancreatitis and jumpstart tumor development. Read the story »

Krainer named Society for RNA Therapeutics board member

4/18/2023

He helped pioneer the field. It changed medicine. Now, he joins a group of renowned scientists and physicians aiming to take it to the next level. Read the story »

From tragedy, a potential pediatric cancer treatment

4/12/2023

CSHL Professor Adrian Krainer, the man behind the “miracle drug” known as Spinraza®, has found a way to fight a deadly pediatric brain cancer in mice. Read the story »

A new treatment approach for cystic fibrosis

7/14/2022

Molecules called antisense oligonucleotides may help lung cells make a protein missing in people with cystic fibrosis. Read the story »

Image of dropper adding liquid to glass laboratory test tube

The promising drug duo that may improve SMA treatment

7/11/2022

Pairing Spinraza® with a second FDA-approved drug may be a new way to improve the drug’s therapeutic effects in spinal muscular atrophy patients. Read the story »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.